Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
FUTURE PATENT WARS
!"#$#%&'(#)*+',-)./"#'
!"#$"%&'()*'(+,-'
Beyond the Smartphone Battles and Bloodbath
#LESDolcera
Panelists
2
IP Analytics Internet Services & Products
Maximising IP Value
Computer Technology
Diverse Electronics
#LESDolcera
Dolcera Analytics
• ./0'1233245#6'735807'/"90':00#'809032;08':&'<23=0%">7'?@'"#8'A"%B0C'"#"3&D=7'C0"A7'$75#6'2$%';%2;%50C"%&'"#"3&D=7';3"E2%A'
• F0'4533'7$AA"%5G0'"'104'B0&'H$"#DC"D90';"%"A0C0%7'40'700'=2%%03"D#6'4033'4533'7;5B07'5#';"C0#C'3"47$5C7'
#LESDolcera
What is a Patent War?
0-"*12'3/41*5-1'I'@"C0#C'4"%7'"%0'0J2%C7':&'A"K2%'C0=/#2326&';3"&0%7'$75#6';"C0#C7'C2'5#=%0"70'2%'70=$%0'A"%B0C'7/"%0''6/#)'3/41*5-1'I'@"C0#C'4"%7'"%0'"'=2A;30L'C0=/#2M306"3':"N306%2$#8'4/0%0'A"K2%'632:"3'12%=07'=2A:"C'12%'7$;%0A"=&'"7'C/0'42%38'4"C=/07'
!"#$%&'()%*#+',%-&.$%$/0+1',%*#2'%2%32*$'*%42.%+5%*#$%630&-+',%5$25&'%&7%8&65$%&7%92.:5;%
Smartphone Patent Suits
Source – PCMag, January 2012 #LESDolcera
Lawsuit Prediction Modeling
• Historical data on the Litigations was extracted and normalized.
• Secondary research was conducted to obtain relevant data for the factors
Data Collection & Cleaning
• Various factors were considered for possible correlation
Regression Analysis • Based on the correlations,
a model was proposed & tested
• The Model is 82% significant in explaining the variability of the factors
Drawing Inferences
Methodology:
#LESDolcera
O57C2%5="3'@"C0#C'P"47$5C'<"C"'
+' (+' Q+' R+' )+' ,++' ,(+'
?#C0%#0C'S1'./5#67'
F0"%":307'
@233$C"#C7'"#8'0J0=C7'2#'7B5#'"#8'/"5%'
T"#20A$3752#7'5#'12287'
U5=%2V$585=7'W'A5=%2;%2=0775#6'
.%"#780%A"3'8%$6'803590%&'
X#0%6&'Y"708'Z$%65="3'Z0"35#6'2%'<5770=D2#'
Z$%65="3'ZC";35#6'
ZA"%C;/2#07'
+' ,+' (+' [+' Q+' -+' R+' \+'
7&-89#139'
?#C0%#0C'S1'./5#67'
F0"%":307'@233$C"#C7'"#8'0J0=C7'2#'7B5#'
"#8'/"5%'
T"#20A$3752#7'5#'12287'
U5=%2V$585=7'W'A5=%2;%2=0775#6'
.%"#780%A"3'8%$6'803590%&'
X#0%6&'Y"708'Z$%65="3'Z0"35#6'2%'<5770=D2#'
Z$%65="3'ZC";35#6' ZA"%C;/2#07'
T$A:0%'21';"C0#C7' ,()(,' ,R+\' ,\\' Q+[' ,]R\' [,,[' )++[' ,)++' R++++'
T$A:0%''21'3"47$5C7'' ](' [Q' ]' R' ,' (R' ,R' ,(' ,,,'
:#;98*%9'<9'!#%/1%9'='>*)*12',#%/9?'@AAA'B'@ACD'
Source – Dolcera, January 2014 #LESDolcera
Model Implementation
No of patents
R&D Spend(in millions USD)
Hype Cycle
NPE
Operating Company
Significant Factors
No of patents
Revenue (in millions USD)
R&D Spend (in millions USD)
Hype Cycle
Non Practicing Entities
Operating Company
Individual inventors
Research Centers & Universities
Considered Influencing Factors
Regression Analysis
#LESDolcera
Predictive Model
The no. of lawsuits in area was found dependent on the factors as below:
No of lawsuits = - 1.027 + 0.0072 * No of patents
+ 0.0011 * R&D Spend (in Millions) - 0.0103 * Hype Cycle - 0.0009 * NPE + 0.0055 * Operating Company
Interactive Dashboard : Sensitivity Analysis
Source – Dolcera, January 2014 #LESDolcera
Real-world Examples
Hi Tech • Internet of
Things • Wearable
Devices
CPG • Pollutants and
Effects on skin and hair
Pharma • Microfluidics &
Micro processing
• Transdermal Drug delivery
Medical Devices • Energy Based
Surgical Sealing or Dissection
• Surgical Stapling
Food & Beverages • Nanoemulsions
in foods
#LESDolcera
O57C2%5="3'@"C0#C'P"47$5C'<"C"'
+' (+' Q+' R+' )+' ,++' ,(+'
?#C0%#0C'S1'./5#67'
F0"%":307'
@233$C"#C7'"#8'0J0=C7'2#'7B5#'"#8'/"5%'
T"#20A$3752#7'5#'12287'
U5=%2V$585=7'W'A5=%2;%2=0775#6'
.%"#780%A"3'8%$6'803590%&'
X#0%6&'Y"708'Z$%65="3'Z0"35#6'2%'<5770=D2#'
Z$%65="3'ZC";35#6'
ZA"%C;/2#07'
+' ,+' (+' [+' Q+' -+' R+' \+'
7&-89#139'
?#C0%#0C'S1'./5#67'
F0"%":307'@233$C"#C7'"#8'0J0=C7'2#'7B5#'
"#8'/"5%'
T"#20A$3752#7'5#'12287'
U5=%2V$585=7'W'A5=%2;%2=0775#6'
.%"#780%A"3'8%$6'803590%&'
X#0%6&'Y"708'Z$%65="3'Z0"35#6'2%'<5770=D2#'
Z$%65="3'ZC";35#6' ZA"%C;/2#07'
T$A:0%'21';"C0#C7' ,()(,' ,R+\' ,\\' Q+[' ,]R\' [,,[' )++[' ,)++' R++++'
T$A:0%''21'3"47$5C7'' ](' [Q' ]' R' ,' (R' ,R' ,(' ,,,'
:#;98*%9'<9'!#%/1%9'='>*)*12',#%/9?'@AAA'B'@ACD'
Direct Correlation between patent count & litigation Source – Dolcera, January 2014
#LESDolcera
Litigations over the years
M-'
+'
-'
,+'
,-'
(+'
(-'
@AAD' @AAE' @AAF' @AAG' @AAH' @AAI' @ACA' @ACC' @AC@' @ACJ' @ACD'
KL*9'7*%)/'
KL*9'7*%)/'
M8$N/"'-O':#;98*%9'
?#C0%#0C'S1'./5#67'
F0"%":30'
U5=%2V$585=7'W'U5=%2;%2=0775#6'
.%"#780%A"3'<%$6'803590%&'
X#0%6&'Y"708'Z$%65="3'Z0"35#6'2%'<5770=D2#'
U085="3'ZC";35#6'
T"#2M0A$3752#7'5#'12287'
Patent lawsuits in Wearables/IOT started before the Hype
Source – Dolcera, January 2014 #LESDolcera
Smartphone Patent Suits
Source – PCMag, January 2012 #LESDolcera
Pollutants and Effects On Skin & Hair
Source – Dolcera, January 2014
Low patent count, Medium R&D spend, Low Hype, Low NPEs
#LESDolcera
Nano-emulsions In Foods
Source – Dolcera, January 2014
Low patent count, Medium R&D spend, Low Hype, No NPEs
#LESDolcera
Surgical Stapling
Source – Dolcera, January 2014
Medium Patent Count, High R&D spend, Low Hype, Low NPEs
#LESDolcera
Energy Based Surgical Sealing or Dissection
Source – Dolcera, January 2014
High Patent Count, High R&D spend, Low Hype, Low NPEs
#LESDolcera
Transdermal Drug Delivery
Source – Dolcera, January 2014
High Patent Count, High R&D spend, Low Hype, Low NPEs
#LESDolcera
Internet of Things
Source – Dolcera, January 2014
High Patent Count, High R&D spend, High Hype, High NPEs
#LESDolcera
Wearables
Source – Dolcera, January 2014
High Patent Count, High R&D spend, High Hype, High NPEs
#LESDolcera
Smartphones
Source – PCMag, January 2012
High Patent Count, High R&D spend, High Hype, High NPEs
#LESDolcera
Top Plaintiffs & Defendants
Technology Area Plaintiff Defendant
Internet Of Things Brandywine Communications, Penovia, LVL Patent Group, B.E. Technology, Microsoft 25% Samsung, Cisco, Microsoft, Nokia, LG 25%
Wearable Red Pine Point , Pragmatus Mobile, PhatRat Technology, Digimarc, Icon Health
46% Samsung, Apple, Lenovo, Nike, Motorola
38%
Smartphones Motorola, Apple, Nokia, Interdigital, Ericsson 67% Apple, HTC, Samsung, Microsoft,
Motorola 70%
Transdermal Drug delivery Senju Pharmaceutical, Allergan, Kyorin Pharmaceutical,Femina Pharma 98%
Apotex, Lupin, Actavis, Aurobindo Pharma, Hi-Tech Pharmacal Co. 79%
Energy Based Surgical Sealing or Dissection
Boston Scientific, Bovie Medical, ConMed , Cook , Ethicon Endo-Surgery
50% Boston Scientific, Covidien Sales, ConMed, L.C. Medical, Mako Surgical 37%
Medical Stapling Medtronic, Warsaw Orthopedic, Osteotech,Cardica
91%
Nuvasive, Medtronic, Osteotech, Integrated Vascular Interventional Tech., Total
100%
Nano-emulsions in foods Elan Pharma International, Fournier Laboratories Ireland
100%
Teva Pharmaceuticals USA, Ranbaxy Laboratories, Impax Laboratories, Lupin, Biovail Labs
77%
Pollutants and Effects on skin & hair Allergan, Duke University 100%
Watson Pharma, Apotex, Hi-Tech Pharmacal, Sandoz, Total 94%
The smartphone patent wars were in a way unique in HighTech
#LESDolcera Source – Dolcera, January 2014
Thank You!!
^2#C"=C'$7_'
!"#$#%&'(#)*+'?'PCBDAHB@D@BE@AG'
;%"A"C/`A"35Ba823=0%"`=2A'
#LESDolcera
Panelists
24
IP Analytics Internet Services & Products
Maximising IP Value
Computer Technology
Diverse Electronics
#LESDolcera
Appendix
Internet of Things
([+'
(+(',]Q'
,))'
,\+'
+'
-+'
,++'
,-+'
(++'
(-+'
Pb'XPX^.cST?^Z'?T^' d.X'^Sc@' ?YU' ZeUZfTb'XPX^.cST?^Z'^S'P.<'
OfeFX?'.X^OTSPSbg'^S'P.<'
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
R1%/"1/%'-O'7&*129'B'7-Q'E'K99*21//9'
Wearables
R+'-\'
-+'
[Q'[('
+'
,+'
(+'
[+'
Q+'
-+'
R+'
\+'
U5=%272h'^2%;' T5B0'?#=' ?YU'^2%;' Z05B2'X;72#'^2%;' i$"3=2AA'?#='
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
S/#"#N)/'7/.&1-)-2T'B'7-Q'E'K99*21//9'
Pollutants and Effects on Skin & Hair
(+'
)'
Q' Q'['
+'
-'
,+'
,-'
(+'
(-'
P2%0"3' e7/3"#8' e330%6"#' Y050%782%1'eb' YeZj'ZX'
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
!-))8%#1%9'#13'UV/.%9'-1'W+*1'X'Y#*"'B'7-Q'E'K99*21//9'
Energy Based Surgical Sealing or Dissection
\Q)'
Q(]' Q()'Q+('
[+)'
+'
,++'
(++'
[++'
Q++'
-++'
R++'
\++'
)++'
^295850#' Y27C2#'Z=50#Dk='^2%;2%"D2#' !2/#72#'W'!2/#72#' S3&A;$7'^2%;2%"D2#' U08C%2#5='?#='
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
U1/"2T'0#9/3'W8"2*.#)'W/#)*12'-"',*99/.5-1'B'7-Q'E'K99*21//9'
Microfluidics & Microprocessing
,[)'
Q-' QQ'[)'
[['
+'
(+'
Q+'
R+'
)+'
,++'
,(+'
,Q+'
,R+'
j$K5'j53A'O2385#67' SL12%8'^"C"3&7C7'b%2$;' ^2%#5#6' O5C"=/5' ^"3512%#5"'f#590%75C&'
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
(R."-Z8*3*.9'X'(R."-Q"-./99*12'B'7-Q'E'K99*21//9'
Nanoemulsions in Foods
(,'
,('
,+']'
)'
+'
-'
,+'
,-'
(+'
(-'
YeZj' f#53090%' j$K$'j53A'^2%;' @/538'^2'PC8' T07C0='Ze'
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
M#1-/$8)9*-19'*1'>--39'B'7-Q'E'K99*21//9'
Surgical Stapling
QRQ'
Q,Q'
[]' [-' [Q'
+'
-+'
,++'
,-+'
(++'
(-+'
[++'
[-+'
Q++'
Q-+'
-++'
!2/#72#'W'!2/#72#' ^295850#' ^"%85="' ?#C$D90'Z$%65="3' U08C%2#5='
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
W8"2*.#)'W%#Q)*12'B'7-Q'E'K99*21//9'
Transdermal Drug Delivery
]R'
)R'
Q\'
[(' [+'
+'
(+'
Q+'
R+'
)+'
,++'
,(+'
!2/#72#'W'!2/#72#' O57"A5C7$'@/"%A"'^2' .%"#7=$C"#02$7'.0=/#2326507'?#='
P2/A"#'./0%";50'Z&7C0A'eb'
Pb'O2$70/238'W'O0"3C/="%0'
M8$
N/"'-O'Q#%/1
%9'
K99*21//'
7"#193/"$#)',"82',/)*</"T'B'7-Q'E'K99*21//9'